Tesamorelin 10mg - CLEARANCE

Our loss is your gain. THIS IS A CLEARANCE ITEM due to only having the foreign COA. 

This Tesamorelin 10mg is for research purposes only. Although this product has been researched, THIS PRODUCT HAS NOT BEEN INDEPENDENTLY 3RD PARTY TESTED by Hoyle Aminos. We partnered with a domestic researching company in order to offer a greater selection as we grow, while still being able to provide a COA. We were under the impression it was independently tested, but upon inspection, that is clearly not the case. Therefore, our loss is your gain, as this product is being placed on CLEARANCE. Independent sourcing and testing will rollout based on quantity demand. We are researchers too, and a sample of each batch is personally researched before being placed into stock. Please reach out with any concerns. 

As researchers, it is imperative that you do your due diligence and fully research prior to making a purchase. Though this product is not intended to be used for human consumption, a basic AI search of human use risks are: 

Tesamorelin, a synthetic form of growth hormone-releasing hormone (GHRH), is a medication that requires careful medical supervision due to its potential risks and side effects. It is most notably approved for treating excess abdominal fat (lipodystrophy) in HIV-infected patients. In this context, it is a research chemical, neither dispensed, nor approved by a doctor and is neither intended to treat any illness, nor is it allowed to be used in a human. 

Here are the key risks associated with Tesamorelin:

1. Increased Risk of Cancer3

Tesamorelin works by stimulating the body's own production of growth hormone (GH), which in turn increases levels of insulin-like growth factor-1 (IGF-1).4 GH and IGF-1 are powerful growth factors that can stimulate cell growth and multiplication.

• Active Malignancy: Tesamorelin is contraindicated in patients with an active malignancy (cancer) because of the risk that the growth factors could stimulate cancer cells to grow and spread more rapidly.5
• History of Cancer: For patients with a history of cancer, the decision to use Tesamorelin must be carefully weighed against the risk of the cancer recurring.

2. Glucose Intolerance and Diabetes6

Growth hormone can interfere with how the body uses sugar, potentially leading to or worsening insulin resistance.7

• Increased Blood Sugar: Tesamorelin may increase blood sugar levels.8
• Diabetes: There is a risk of developing or worsening diabetes mellitus.9 Patients with pre-existing diabetes need to be closely monitored and may require adjustments to their diabetes medication.10
  

3. Fluid Retention (Edema)11

An increase in growth hormone can cause the body to retain fluid, leading to a condition called edema.12 This can manifest as:

• Swelling in the hands, feet, and ankles.13
• Joint pain (arthralgia).14
• Carpal tunnel syndrome, characterized by pain, tingling, and numbness in the hands and wrists.15

 4. Hypersensitivity Reactions16

Serious allergic reactions are a risk.17 Signs of a severe reaction that require immediate medical attention include:

• Hives, rash, or itching.18
• Swelling of the face, lips, tongue, or throat.19
• Difficulty breathing.20
• Fast heartbeat, dizziness, or fainting.21
  

5. Injection Site Reactions

As with many injectable medications, Tesamorelin can cause local reactions at the injection site.22 These are often mild but can include:

• Redness, itching, pain, or swelling.23
• Bleeding or bruising.24
  

6. Other Potential Risks

• Pituitary Issues: Tesamorelin is contraindicated in patients with a history of pituitary gland problems, such as a tumor, surgery, head trauma, or radiation to the head.25
• Pregnancy and Lactation: Tesamorelin is contraindicated in pregnant women as it can harm the fetus.26Its use is not recommended while breastfeeding.27
• Drug Interactions: Tesamorelin can interact with other medications, particularly corticosteroids.28
  

Due to these risks, it is essential that anyone considering Tesamorelin use does so under the strict supervision of a qualified healthcare professional. Regular monitoring of blood sugar, IGF-1 levels, and overall health is necessary to mitigate these risks.

https://www.goodrx.com/egrifta-sv/what-is